Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RNAi
RNAi
Alnylam's star RNAi drug keeps the pace on the way to Phase III
Fierce Biotech
Tue, 04/21/15 - 12:20 pm
Alnylam
RNAi
Patisiran
ATTR
Silence Therapeutics raises $58 million to advance R&D
BioPharma Dive
Thu, 04/9/15 - 03:12 pm
Silence Therapeutics
RNAi
R&D
Novartis sells its RNAi cast-offs from Alnylam in $35M fire sale to Arrowhead
Fierce Biotech
Thu, 03/5/15 - 08:21 am
Novartis
Alnylam
RNAi
Arrowhead Research
Alnylam reports results from Phase 2 revusiran trial
Seeking Alpha
Fri, 11/14/14 - 09:54 am
Alnylam
revusiran
TTR cardiac amyloidosis
RNAi
Study Suggests RNAi Drug Has Potential in Ebola Treatment
WSJ Pharmalot
Fri, 08/22/14 - 12:11 pm
ebola virus
Tekmira Pharmaceuticals
RNAi
NP-718m-LNP
5 Huge Biotech Catalysts Right Around the Corner for Top Stocks
24/7 Wall St
Mon, 07/28/14 - 12:26 pm
Arrowhead Research
Gilead Sciences
Intercept Pharmaceuticals
Amgen
Vertex Pharmaceuticals
RNAi
Kyprolis
VX-661
Sovaldi
Kalydeco
Is This the Crown Jewel of the ISIS Pipeline?
Motley Fool
Tue, 07/8/14 - 04:50 pm
Isis Pharmaceuticals
RNAi
ISIS-APOCIIIRx
Alnylam Strikes Back: Comments From CEO John Maraganore
Forbes
Wed, 04/23/14 - 10:19 am
Pharma CEOs
John Maraganore
Alnylam
RNAi
Big Pharma's Turn On RNAi Shows That New Technologies Don't Guarantee R&D Success
Forbes
Tue, 04/15/14 - 10:35 am
Big Pharma
RNAi
Novartis
Alnylam
Alnylam slips after Novartis reportedly cuts back RNAi development
The Fly on the Wall
Mon, 04/14/14 - 06:22 pm
Novartis
Alnylan
RNAi
Arrowhead: A Functional Cure For The Hepatitis B Virus
Seeking Alpha
Wed, 02/19/14 - 12:49 pm
Arrowhead Research
hepatitis B
RNAi
Rise of Alnylam, ISIS Gives RNA Therapeutics Value
Wall St Cheat Sheet
Wed, 02/19/14 - 10:17 am
Alnylam
Isis Pharmaceuticals
RNAi
Merck's RNAi Trash is Alnylam's Treasure
Motley Fool
Fri, 01/24/14 - 09:10 am
Merck
RNAi
Alnylam
patents
Alnylam Snaps Up Merck’s Sirna Therapeutics
Wall St Cheat Sheet
Mon, 01/13/14 - 02:51 pm
siRNA
M&A
Merck
Alnylam
RNAi
RNAi Developer Dicerna Pharmaceuticals to IPO
Nanalyze
Sun, 01/5/14 - 12:34 pm
RNAi
Dicerna Pharmaceuticals
IPO
Alnylam Pharmaceuticals, Inc.: The Best Performing Biotechs of 2013
Motley Fool
Thu, 12/26/13 - 01:52 pm
RNAi
Alnylam
Alnylam Pharmaceuticals, Inc.: The Best Performing Biotechs of 2013
Motley Fool
Thu, 12/26/13 - 01:51 pm
Alnylam
RNAi
Alnylam's Biggest Opportunities
Motley Fool
Wed, 10/2/13 - 10:02 am
Alnylam
RNAi
ATTR
hemophilia
porphyria
Alnylam Soars To New High On Early Drug Trial Results
Investors.com
Fri, 07/12/13 - 07:32 am
Alnylam
RNAi
ALN-TTRsc
Alnylam announces proof-of-concept data from RNAi program
Yahoo/Fly on the Wall
Fri, 05/17/13 - 11:28 am
Alnylam
RNAi
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »